Biotech Industry articles & resources on Made-in-China.com

Taiwan's Biotech Industry Likely to Receive Significant Investment From European Countries

Nov 22, 2017

Looking at the great growth potential of Taiwan's bio-technology industry, Henri Lenferink, the mayor of Leiden, a city and municipality in the Dutch province of South Holland, led a delegation to Taiwan earlier, discussing cooperation ...

Tags: Biotech Industry

A Much-Discussed Piece on The Discrepancy Between Corporate Profits and Labor Compensation

Jan 13, 2014

This is a guest post. The views expressed here are solely those of the author and do not represent positions of IEEE Spectrum or the IEEE. Two years ago, New York Times columnist Paul Krugman wrote a much-discussed piece on the ...

Tags: Robotics Industry, Robot

Health R&D Spending Moves Slowly Upward Driven by Industry

Dec 20, 2013

Health R&D Spending Moves Slowly Upward, Driven by Industry, Philanthropy and Voluntary Health Associations Federal R&D Funding Remains "Woefully Inadequate" to Address Health Threats and Global Competitiveness ?Highlights: ?Overall ...

Tags: Health, Medicine

Health-related R&D Spending in The U.S.Increased by $4.3 Billion in FY11-12

Dec 20, 2013

After declining in FY10-11,health-related research and development(R&D)spending in the U.S.increased by$4.3 billion(3.5%)in FY11-12,according to Truth and Consequences:Health R&D Spending in the U.S.(FY11-12),the 10th edition from ...

Tags: Health R&D Spending, R&D of Health

US-Based Moderna Therapeutics Has Announced The Completion of a New Financing Round

Nov 25, 2013

US-based Moderna Therapeutics has announced the completion of a new financing round, raising $110m to develop messenger RNA Therapeutics. In aggregate, Moderna has secured more than $415m in financing and partnerships to date from the ...

Tags: Moderna, Medicine

The Willingness of CROs to Invest in State-of-The-Art Facilities

Feb 18, 2013

Pharmaceutical and biotech companies are outsourcing research in order to develop innovative products that meet the rising demand for therapeutics across a range of diseases. The willingness of contract research organisations (CROs) to ...

Tags: Pharmaceutical, CROs, innovative products

Omkar Speciality Chemicals Is Planning to Invest INR250m to Expand The Production Capacity

Dec 25, 2012

Omkar Speciality Chemicals is planning to invest INR250m ($4.67m) to expand the production capacity from current 1,700 to 1,950 tons at its active pharmaceutical ingredient (API) facility in Badlapur, Maharashtra, India. Omkar Speciality ...

Tags: Omkar, production capacity, Speciality Chemicals

Urumqi Economic and Technological Development Zone

Dec 11, 2012

(i)National Development Zones 1.Urumqi Economic and Technological Development Zone It was approved by the State Council on August 25, 1994 as a national development zone. The Zone covers a planned area of 16.84 sq. km. We put the Zone ...

Tags: Xinjiang Uygur Autonomous Region, survey, economy, investment

The Cabinet Has Put Forth a Plan for Appropriating NT$300 Million in Three Years

Oct 28, 2012

Taipei, Oct. 22, 2012 (CENS)--The Executive Yuan (the Cabinet) has put forth a plan for appropriating NT$300 million in three years, which will be used to subsidize the pays of 300 biotech doctors for receiving one–year re-training at ...

Tags: the Cabinet, high-caliber talent

The Government Will Push The Establishment of Big Biotech Venture Capital Fund

Oct 17, 2012

Taipei,Oct.18,2012--The scientific and technology task force of the Executive Yuan(the Cabinet)approved yesterday(Oct.17)the revised action program for the takeoff of the Taiwanese biotech industry,according to which the government will ...

Tags: Taipei, government, biotech funds, medical

Industrial Cooperation Between Taiwan and Japan Is Undergoing Subtle Change

Sep 19, 2012

Taipei,Sept.19,2012(CENS)--At a time when China-Japan relationship has become tense,industrial cooperation between Taiwan and Japan is undergoing subtle change.During his visit to Japan last week,Yiin Chii-min,minister of the Council for ...

Tags: Investments, Rise, Change, Cooperation

Insmed Has Named Will Lewis as President and Chief Executive Officer

Sep 13, 2012

Insmed, a biopharmaceutical company developing inhalation therapeutics for patients suffering from orphan lung diseases, has named Will Lewis as president and chief executive officer. Lewis has also been appointed to the company's board ...

Tags: Medicine, Health

Biotech Industry

Related Products